253 related articles for article (PubMed ID: 15590129)
1. Fumonisin B1 hepatotoxicity in mice is attenuated by depletion of Kupffer cells by gadolinium chloride.
He Q; Kim J; Sharma RP
Toxicology; 2005 Feb; 207(1):137-47. PubMed ID: 15590129
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of tumor necrosis factor alpha signaling by anti-tumor necrosis factor alpha antibodies and pentoxifylline is unable to prevent fumonisin hepatotoxicity in mice.
He Q; Sharma RP
Toxicon; 2005 Sep; 46(4):404-13. PubMed ID: 16054185
[TBL] [Abstract][Full Text] [Related]
3. Silymarin protects against liver damage in BALB/c mice exposed to fumonisin B1 despite increasing accumulation of free sphingoid bases.
He Q; Kim J; Sharma RP
Toxicol Sci; 2004 Aug; 80(2):335-42. PubMed ID: 15103051
[TBL] [Abstract][Full Text] [Related]
4. Lupus-prone NZBWF1/J mice, defective in cytokine signaling, are resistant to fumonisin hepatotoxicity despite accumulation of liver sphinganine.
Sharma RP; He Q; Riley RT
Toxicology; 2005 Dec; 216(1):59-71. PubMed ID: 16159691
[TBL] [Abstract][Full Text] [Related]
5. Fumonisin B1-induced localized activation of cytokine network in mouse liver.
Bhandari N; Brown CC; Sharma RP
Food Chem Toxicol; 2002 Oct; 40(10):1483-91. PubMed ID: 12387313
[TBL] [Abstract][Full Text] [Related]
6. Gender-related differences in subacute fumonisin B1 hepatotoxicity in BALB/c mice.
Bhandari N; He Q; Sharma RP
Toxicology; 2001 Aug; 165(2-3):195-204. PubMed ID: 11522378
[TBL] [Abstract][Full Text] [Related]
7. Inducible nitric oxide has protective effect on fumonisin B1 hepatotoxicity in mice via modulation of sphingosine kinase.
Suzuki H; Riley RT; Sharma RP
Toxicology; 2007 Jan; 229(1-2):42-53. PubMed ID: 17095132
[TBL] [Abstract][Full Text] [Related]
8. The protective role of liver X receptor (LXR) during fumonisin B1-induced hepatotoxicity.
Régnier M; Polizzi A; Lukowicz C; Smati S; Lasserre F; Lippi Y; Naylies C; Laffitte J; Bétoulières C; Montagner A; Ducheix S; Gourbeyre P; Ellero-Simatos S; Menard S; Bertrand-Michel J; Al Saati T; Lobaccaro JM; Burger HM; Gelderblom WC; Guillou H; Oswald IP; Loiseau N
Arch Toxicol; 2019 Feb; 93(2):505-517. PubMed ID: 30448865
[TBL] [Abstract][Full Text] [Related]
9. Decreased fumonisin hepatotoxicity in mice with a targeted deletion of tumor necrosis factor receptor 1.
Sharma RP; Bhandari N; He Q; Riley RT; Voss KA
Toxicology; 2001 Feb; 159(1-2):69-79. PubMed ID: 11250056
[TBL] [Abstract][Full Text] [Related]
10. Myriocin prevents fumonisin B1-induced sphingoid base accumulation in mice liver without ameliorating hepatotoxicity.
He Q; Riley RT; Sharma RP
Food Chem Toxicol; 2005 Jun; 43(6):969-79. PubMed ID: 15811577
[TBL] [Abstract][Full Text] [Related]
11. Fumonisin hepatotoxicity is reduced in mice carrying the human tumour necrosis factor alpha transgene.
Sharma RP; Bhandari N; Tsunoda M; Riley RT; Voss KA
Arch Toxicol; 2000 Jul; 74(4-5):238-48. PubMed ID: 10959799
[TBL] [Abstract][Full Text] [Related]
12. Tolerance to fumonisin toxicity in a mouse strain lacking the P75 tumor necrosis factor receptor.
Sharma RP; Bhandari N; Riley RT; Voss KA; Meredith FI
Toxicology; 2000 Feb; 143(2):183-94. PubMed ID: 10755704
[TBL] [Abstract][Full Text] [Related]
13. Toxic effects of fumonisin in mouse liver are independent of the peroxisome proliferator-activated receptor alpha.
Voss KA; Liu J; Anderson SP; Dunn C; Miller JD; Owen JR; Riley RT; Bacon CW; Corton JC
Toxicol Sci; 2006 Jan; 89(1):108-19. PubMed ID: 16221962
[TBL] [Abstract][Full Text] [Related]
14. Amelioration of fumonisin B1 hepatotoxicity in mice by depletion of T cells with anti-Thy-1.2.
Sharma N; He Q; Sharma RP
Toxicology; 2006 Jun; 223(3):191-201. PubMed ID: 16690192
[TBL] [Abstract][Full Text] [Related]
15. Fumonisin B1-induced neurodegeneration in mice after intracerebroventricular infusion is concurrent with disruption of sphingolipid metabolism and activation of proinflammatory signaling.
Osuchowski MF; Edwards GL; Sharma RP
Neurotoxicology; 2005 Mar; 26(2):211-21. PubMed ID: 15713342
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of CD95-ligand and other apoptotic signaling factors by fumonisin B1, a hepatotoxic mycotoxin, in livers of mice lacking tumor necrosis factor alpha.
Sharma RP; He Q; Johnson VJ; Voss KA
Cytokine; 2003 Dec; 24(5):226-36. PubMed ID: 14596819
[TBL] [Abstract][Full Text] [Related]
17. S-adenosylmethionine or 5'-methylthioadenosine are unable to prevent fumonisin B1 hepatotoxicity in mice despite increased oxidation in liver.
He Q; Suzuki H; Sharma RP
J Appl Toxicol; 2006; 26(6):509-16. PubMed ID: 17080400
[TBL] [Abstract][Full Text] [Related]
18. Mice lacking both TNFalpha receptors show increased constitutive expression of IFNgamma: a possible reason for lack of protection from fumonisin B1 hepatotoxicity.
Sharma RP; He Q; Johnson VJ; Suzuki H
Cytokine; 2006 Jun; 34(5-6):260-70. PubMed ID: 16884913
[TBL] [Abstract][Full Text] [Related]
19. 15-hydroxyprostaglandin dehydrogenase (15-PGDH) prevents lipopolysaccharide (LPS)-induced acute liver injury.
Yao L; Chen W; Song K; Han C; Gandhi CR; Lim K; Wu T
PLoS One; 2017; 12(4):e0176106. PubMed ID: 28423012
[TBL] [Abstract][Full Text] [Related]
20. Pretreatment with lipopolysaccharide ameliorates Pseudomonas exotoxin A-induced hepatotoxicity in rats.
Chiu CC; Huang YT; Wang YC; Chang YC; Ching YH; Chen HH; Chuang HL
Immunopharmacol Immunotoxicol; 2013 Apr; 35(2):296-303. PubMed ID: 23384342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
